Dr. H. Bliss Murphy Cancer Centre-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2013

  1. Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

    The Lancet Oncology, Vol. 14, Núm. 1, pp. 72-80

2005

  1. Adjuvant docetaxel for node-positive breast cancer

    New England Journal of Medicine, Vol. 352, Núm. 22, pp. 2302-2313